C
PPH icon

Certuity’s VanEck Pharmaceutical ETF PPH Stock Holding History

Certuity’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
2,804
+22
+0.8% +$2.28K 0.02% 494
2026
Q1 		$289K Sell
2,782
-4
-0.1% -$426 0.02% 473
2025
Q4 		$288K Sell
2,786
-41
-1% -$3.99K 0.02% 430
2025
Q3 		$255K Buy
2,827
+20
+0.7% +$1.75K 0.02% 446
2025
Q2 		$247K Buy
2,807
+16
+0.6% +$1.39K 0.02% 343
2025
Q1 		$254K Buy
+2,791
New +$251K 0.03% 316

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Certuity's PPH Position: Q2 2026 in Review

Certuity increased its VanEck Pharmaceutical ETF (PPH) stake by 0.79% in Q2 2026, buying an estimated $2.28K and bringing the position to 2,804 shares worth $307K. The position accounts for 0.02% of the portfolio, ranked #494.

Certuity first reported a position in PPH in Q1 2025 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Certuity held 2,804 shares of VanEck Pharmaceutical ETF worth $307K as of Q2 2026.
  • Certuity bought 22 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $2.28K.
  • VanEck Pharmaceutical ETF made up 0.02% of Certuity's portfolio in Q2 2026, its #494 holding.
  • Certuity first reported a position in VanEck Pharmaceutical ETF in Q1 2025 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.